vs
自然阳光（NATR）与GIBRALTAR INDUSTRIES, INC.（ROCK）财务数据对比。点击上方公司名可切换其他公司
GIBRALTAR INDUSTRIES, INC.的季度营收约是自然阳光的1.8倍（$225.0M vs $123.8M），GIBRALTAR INDUSTRIES, INC.同比增速更快（24.9% vs 4.7%），GIBRALTAR INDUSTRIES, INC.自由现金流更多（$26.2M vs $7.6M），过去两年自然阳光的营收复合增速更高（5.6% vs -12.3%）
自然阳光产品公司（简称NSP）主营膳食补充剂与个人护理产品的生产制造，产品涵盖草本补充剂、维生素、矿物质制剂等品类。公司总部设于犹他州利希，生产工厂位于犹他州西班牙福克，是该领域知名的健康产品生产商。
直布罗陀工业公司是专业建筑、基础设施及可再生能源产品制造商与分销商，主营通风系统、屋面配件、太阳能安装支架、园林景观产品等，主要服务北美地区住宅、商业建筑及清洁能源市场，专注提供创新可持续的客户解决方案。
NATR vs ROCK — 直观对比
营收规模更大
ROCK
是对方的1.8倍
$123.8M
营收增速更快
ROCK
高出20.2%
4.7%
自由现金流更多
ROCK
多$18.7M
$7.6M
两年增速更快
NATR
近两年复合增速
-12.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $123.8M | $225.0M |
| 净利润 | $4.1M | — |
| 毛利率 | 72.5% | 25.3% |
| 营业利润率 | 4.3% | 7.9% |
| 净利率 | 3.3% | — |
| 营收同比 | 4.7% | 24.9% |
| 净利润同比 | 1379.4% | — |
| 每股收益（稀释后） | $0.23 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NATRROCK
| Q4 25 | $123.8M | $225.0M | ||
| Q3 25 | $128.3M | $310.9M | ||
| Q2 25 | $114.8M | $309.5M | ||
| Q1 25 | $113.2M | $290.0M | ||
| Q4 24 | $118.2M | $180.1M | ||
| Q3 24 | $114.6M | $277.1M | ||
| Q2 24 | $110.6M | $273.6M | ||
| Q1 24 | $111.0M | $292.5M |
净利润NATRROCK
| Q4 25 | $4.1M | — | ||
| Q3 25 | $5.3M | $-89.1M | ||
| Q2 25 | $5.3M | $26.0M | ||
| Q1 25 | $4.7M | $21.1M | ||
| Q4 24 | $-321.0K | — | ||
| Q3 24 | $4.3M | $34.0M | ||
| Q2 24 | $1.3M | $32.2M | ||
| Q1 24 | $2.3M | $24.9M |
毛利率NATRROCK
| Q4 25 | 72.5% | 25.3% | ||
| Q3 25 | 73.3% | 26.6% | ||
| Q2 25 | 71.7% | 28.4% | ||
| Q1 25 | 72.1% | 26.8% | ||
| Q4 24 | 72.0% | 29.0% | ||
| Q3 24 | 71.3% | 29.4% | ||
| Q2 24 | 71.4% | 30.5% | ||
| Q1 24 | 71.2% | 28.9% |
营业利润率NATRROCK
| Q4 25 | 4.3% | 7.9% | ||
| Q3 25 | 7.0% | 12.8% | ||
| Q2 25 | 3.7% | 12.8% | ||
| Q1 25 | 5.4% | 8.8% | ||
| Q4 24 | 3.8% | 13.3% | ||
| Q3 24 | 4.6% | 15.6% | ||
| Q2 24 | 5.1% | 14.9% | ||
| Q1 24 | 4.2% | 10.8% |
净利率NATRROCK
| Q4 25 | 3.3% | — | ||
| Q3 25 | 4.2% | -28.6% | ||
| Q2 25 | 4.6% | 8.4% | ||
| Q1 25 | 4.2% | 7.3% | ||
| Q4 24 | -0.3% | — | ||
| Q3 24 | 3.8% | 12.3% | ||
| Q2 24 | 1.2% | 11.8% | ||
| Q1 24 | 2.1% | 8.5% |
每股收益（稀释后）NATRROCK
| Q4 25 | $0.23 | — | ||
| Q3 25 | $0.30 | $-2.98 | ||
| Q2 25 | $0.28 | $0.87 | ||
| Q1 25 | $0.25 | — | ||
| Q4 24 | $-0.02 | — | ||
| Q3 24 | $0.23 | $1.11 | ||
| Q2 24 | $0.07 | $1.05 | ||
| Q1 24 | $0.12 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $93.9M | $115.7M |
| 总债务越低越好 | — | $0 |
| 股东权益账面价值 | $161.6M | $950.4M |
| 总资产 | $261.1M | $1.4B |
| 负债/权益比越低杠杆越低 | — | 0.00× |
8季度趋势，按日历期对齐
现金及短期投资NATRROCK
| Q4 25 | $93.9M | $115.7M | ||
| Q3 25 | $95.6M | $89.4M | ||
| Q2 25 | $81.3M | $43.3M | ||
| Q1 25 | $86.5M | $25.1M | ||
| Q4 24 | $84.7M | $269.5M | ||
| Q3 24 | $78.7M | $228.9M | ||
| Q2 24 | $68.7M | $179.1M | ||
| Q1 24 | $77.8M | $146.7M |
总债务NATRROCK
| Q4 25 | — | $0 | ||
| Q3 25 | — | $0 | ||
| Q2 25 | — | $0 | ||
| Q1 25 | — | $0 | ||
| Q4 24 | — | $0 | ||
| Q3 24 | — | $0 | ||
| Q2 24 | — | $0 | ||
| Q1 24 | $2.1M | $0 |
股东权益NATRROCK
| Q4 25 | $161.6M | $950.4M | ||
| Q3 25 | $166.7M | $951.8M | ||
| Q2 25 | $163.7M | $1.0B | ||
| Q1 25 | $167.1M | $1.0B | ||
| Q4 24 | $161.0M | $1.0B | ||
| Q3 24 | $162.6M | $1.0B | ||
| Q2 24 | $156.4M | $975.7M | ||
| Q1 24 | $159.7M | $940.2M |
总资产NATRROCK
| Q4 25 | $261.1M | $1.4B | ||
| Q3 25 | $264.8M | $1.4B | ||
| Q2 25 | $254.9M | $1.5B | ||
| Q1 25 | $252.7M | $1.4B | ||
| Q4 24 | $240.9M | $1.4B | ||
| Q3 24 | $245.3M | $1.4B | ||
| Q2 24 | $235.8M | $1.4B | ||
| Q1 24 | $247.3M | $1.3B |
负债/权益比NATRROCK
| Q4 25 | — | 0.00× | ||
| Q3 25 | — | 0.00× | ||
| Q2 25 | — | 0.00× | ||
| Q1 25 | — | 0.00× | ||
| Q4 24 | — | 0.00× | ||
| Q3 24 | — | 0.00× | ||
| Q2 24 | — | 0.00× | ||
| Q1 24 | 0.01× | 0.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $9.9M | $35.5M |
| 自由现金流经营现金流 - 资本支出 | $7.6M | $26.2M |
| 自由现金流率自由现金流/营收 | 6.1% | 11.7% |
| 资本支出强度资本支出/营收 | 1.9% | 4.1% |
| 现金转化率经营现金流/净利润 | 2.41× | — |
| 过去12个月自由现金流最近4个季度 | $28.8M | $120.6M |
8季度趋势，按日历期对齐
经营现金流NATRROCK
| Q4 25 | $9.9M | $35.5M | ||
| Q3 25 | $18.5M | $73.0M | ||
| Q2 25 | $4.3M | $44.9M | ||
| Q1 25 | $2.6M | $13.7M | ||
| Q4 24 | $12.2M | $19.9M | ||
| Q3 24 | $9.6M | $64.7M | ||
| Q2 24 | $1.3M | $36.5M | ||
| Q1 24 | $2.2M | $53.2M |
自由现金流NATRROCK
| Q4 25 | $7.6M | $26.2M | ||
| Q3 25 | $16.8M | $64.8M | ||
| Q2 25 | $3.0M | $27.3M | ||
| Q1 25 | $1.5M | $2.3M | ||
| Q4 24 | $10.0M | $14.1M | ||
| Q3 24 | $7.9M | $60.5M | ||
| Q2 24 | $-2.0M | $33.5M | ||
| Q1 24 | $-1.5M | $48.8M |
自由现金流率NATRROCK
| Q4 25 | 6.1% | 11.7% | ||
| Q3 25 | 13.1% | 20.8% | ||
| Q2 25 | 2.6% | 8.8% | ||
| Q1 25 | 1.3% | 0.8% | ||
| Q4 24 | 8.5% | 7.8% | ||
| Q3 24 | 6.9% | 21.8% | ||
| Q2 24 | -1.9% | 12.2% | ||
| Q1 24 | -1.4% | 16.7% |
资本支出强度NATRROCK
| Q4 25 | 1.9% | 4.1% | ||
| Q3 25 | 1.3% | 2.6% | ||
| Q2 25 | 1.2% | 5.7% | ||
| Q1 25 | 1.0% | 3.9% | ||
| Q4 24 | 1.9% | 3.3% | ||
| Q3 24 | 1.5% | 1.5% | ||
| Q2 24 | 3.0% | 1.1% | ||
| Q1 24 | 3.3% | 1.5% |
现金转化率NATRROCK
| Q4 25 | 2.41× | — | ||
| Q3 25 | 3.46× | — | ||
| Q2 25 | 0.81× | 1.73× | ||
| Q1 25 | 0.55× | 0.65× | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.21× | 1.90× | ||
| Q2 24 | 0.97× | 1.13× | ||
| Q1 24 | 0.94× | 2.13× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NATR
| Other | $68.1M | 55% |
| General Health Products | $20.2M | 16% |
| Digestive Products | $13.8M | 11% |
| Cardiovascular Products | $12.1M | 10% |
| Personal Care Products | $4.4M | 4% |
| Immunity Products | $3.1M | 3% |
| Weight Management Products | $2.1M | 2% |
ROCK
| Transferred At Point In Time | $183.5M | 82% |
| Infrastructure | $22.5M | 10% |
| Other | $18.9M | 8% |
